High-density lipoprotein particles in octogenarians.

[1]  G. Cazzolato,et al.  ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS? , 1979, The Lancet.

[2]  P. Alaupovic,et al.  Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[3]  G. Fex,et al.  Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol. , 1986, Atherosclerosis.

[4]  N. Al-Muhtaseb,et al.  Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction , 1986 .

[5]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[6]  J. Patsch,et al.  Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. , 1974, European journal of biochemistry.

[7]  T. Ohta,et al.  Studies on the lipid and apolipoprotein compositions of two species of apoA-I-containing lipoproteins in normolipidemic males and females. , 1988, Journal of lipid research.

[8]  J. Albers,et al.  Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. , 1984, The Journal of biological chemistry.

[9]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[10]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. , 1988, Transactions of the American Clinical and Climatological Association.

[11]  J. Deslypere,et al.  Discriminative value of lipids and apoproteins in coronary heart disease. , 1982, Atherosclerosis.

[12]  J. Fruchart,et al.  Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. , 1987, Clinical chemistry.

[13]  J. Fruchart,et al.  Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.

[14]  E. Nikkilä.  SERUM HIGH-DENSITY-LIPOPROTEIN AND CORONARY HEART-DISEASE , 1976 .

[15]  E. Nikkila.  Letter: Serum high-density-lipoprotein and coronary heart-disease. , 1976, Lancet.

[16]  H. Wieland,et al.  Chromatofocusing of human high density lipoproteins and isolation of lipoproteins A and A-I. , 1983, Biochimica et biophysica acta.

[17]  C. Packard,et al.  Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. , 1983, Biochimica et biophysica acta.

[18]  L. Colomo,et al.  Reference intervals for serum lipids, lipoproteins, and apoproteins in the elderly. , 1984, Clinical chemistry.

[19]  C. Wilhelmsson,et al.  Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors. Apolipoprotein A-I levels in male survivors of myocardial infarction. , 1980, Atherosclerosis.

[20]  J. Salonen,et al.  Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. , 1985, The American journal of cardiology.

[21]  J. Fruchart,et al.  Quantitative determination of human plasma apolipoprotein A-II by a non competitive enzyme-linked immunosorbent assay. , 1986, Journal of Immunoassay.

[22]  Arthur F. Krieg,et al.  Faster enzymatic procedure for serum triglycerides. , 1975, Clinical chemistry.

[23]  J. Fruchart,et al.  Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. , 1990, Clinical chemistry.

[24]  S. Isomura,et al.  CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS , 1976, The Lancet.

[25]  J. Fruchart,et al.  Apolipoprotein A-I containing lipoproteins in coronary artery disease. , 1987, Atherosclerosis.

[26]  D. Platt,et al.  Hyper-alpha-lipoproteinemia and hypo-beta-lipoproteinemia are not markers for a high life expectancy. Serum lipid and lipoprotein findings in 103 randomly selected nonagenarians. , 1982, Gerontology.

[27]  J. Albers,et al.  Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios. , 1979, Journal of lipid research.

[28]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[29]  L. Carlson,et al.  Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction. , 1975, Atherosclerosis.

[30]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[31]  L. Carlson.  Serum lipids in men with myocardial infarction. , 2009, Acta medica Scandinavica.

[32]  W. Kannel,et al.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.

[33]  D. Thelle,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[34]  C. Fielding,et al.  Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Glueck,et al.  Lipid and lipoprotein distributions in octo- and nonagenarians. , 1979, Metabolism: clinical and experimental.

[36]  C. Glueck,et al.  Hyperalpha- and hypobeta-lipoproteinemia in octogenarian kindreds. , 1977, Atherosclerosis.

[37]  J. Fruchart,et al.  Lipoproteins, apolipoproteins and coronary artery disease assessed by coronary arteriography , 1982 .

[38]  G. Franceschini,et al.  Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis. , 1987, Atherosclerosis.

[39]  D. Ballantyne,et al.  High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. , 1982, Metabolism: clinical and experimental.